CompletedNot Applicable

Brugada Ablation of VF Substrate Ongoing MultiCenter Registry

Thailand159 participantsStarted 2017-07-01

Plain-language summary

Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates. Exclusion Criteria: * Patients who will not commit to regular follow up.

What they're measuring

Death

Timeframe: 3 years

ICD Therapy for VT/VF

Timeframe: 3 years

Trial details

NCT IDNCT04420078

SponsorPacific Rim Electrophysiology Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More Brugada Syndrome trials